Blog

Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024

Photo taken from Giuseppe Curigliano/LinkedIn

Jun 5, 2024, 06:27

Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024

Giuseppe Curigliano shared on LinkedIn: .

“Proud to serve on the Educational Committee for ASCO2024 under the visionary and inclusive leadership of Dr. Lynn Schuchter.

Together, we’re shaping the future of oncology education and advancing cancer care for all”

Source: Giuseppe Curigliano/LinkedIn

Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.

ASCO ASCO24 cancer cancer care Early Drug Development Division Educational Committee European Institute of Oncology Giuseppe Curigliano Lynn Schuchter OncoDaily Oncology University of Milan

New Paper Alert: Hepatocellular Carcinoma - Stereotactic Body Radiotherapy vs Sorafenib Alone in the NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial - JAMA Oncology

Monica Bertagnolli: 2024 Science Highlights from the NIH Director’s Blog

365 Days of OncoDaily: Ending 2024 Strong

Aladina Foundation was Honored with the Yvonne Humanitarian Award by OncoDaily

Rod Stewart and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage